Clinical And Anatomic Study Of An Ultrasound-Guided Superior Trunk Of The Brachial Plexus
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03512990 |
|
Recruitment Status : Unknown
Verified April 2018 by Leonardo Henrique Cunha Ferraro, Federal University of São Paulo.
Recruitment status was: Recruiting
First Posted : May 1, 2018
Last Update Posted : May 1, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Introduction
Interscalene brachial plexus block is the most commonly performed regional anesthesia technique to promote analgesia for shoulder surgeries. However, one of limitations is the risk of phrenic nerve palsy despite injection of low volumes, being contraindicated in patients with limited pulmonary reserve.
Burckett-St.Laurent et al described an alternative approach to avoid phrenic block - the superior trunk approach.
In this case series, the investigators suggest a modification of Burckett-St.Laurent's technique. The objective of this study is to evaluate efficacy, phrenic nerve function and contrast dispersion in cadavers after performing this new approach.
Materials and methods
The study was approved by Institutional Review Board of our institution. To perform the superior trunk approach described by Burckett-St.Laurent, C5 and C6 nerve roots are identified within the interscalene groove and traced distally to where they coalesce into the superior trunk, proximal to the takeoff of the suprascapular nerve. Burckett-St.Laurent et al suggest spreading local anesthetic around superior trunk at this point.
The investigators suggest an injection more distally, where superior trunk is in costoclavicular space below omohyoid muscle, proximal to the suprascapular outlet. The needle is advanced below the prevertebral layer of deep cervical fascia, avoiding that the tip of the needle lies in the fascial plane between investing layer of deep vertebral fascia and prevertebral layer, a loose fascial plane where lymph node chain is located and may allow postero-anterior dispersion toward phrenic. To guarentee right position of the tip the investigators suggest an intracluster pattern of spread.
Patients scheduled for rotator cuff surgery will receive 6 mL of 0,5% bupivacaine in this new approach. Successful block is defined as motor score of ≤ 2 on modified Bromage scale in the deltoid and bíceps; absent sensation to cold and pinprick sensation in C5 and C6 dermatomes within 30 minutes of injection.
To evaluate phrenic nerve, diaphragmatic excursion will be assessed by ultrasonography of ipsilateral hemidiaphragm and impedance tomography. Pain scores and analgesic consumption will be assessed in PACU.
Moreover, 6 mL of methylene blue will be injected into cadavers to evaluate if dispersion is restricted to fibers of the superior trunk and don't reach phrenic nerve.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Brachial Plexus Block Shoulder Surgery | Procedure: Bupivacaine - Superior Trunk Block | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 10 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Intervention Model Description: | We suggest an injection more distally, where superior trunk is in costoclavicular space below omohyoid muscle, proximal to the suprascapular outlet. The needle is advanced below the prevertebral layer of deep cervical fascia, avoiding that the tip of the needle lies in the fascial plane between investing layer of deep vertebral fascia and prevertebral layer. Patients scheduled for rotator cuff surgery will receive 6 mL of 0,5% bupivacaine. Successful block is defined as motor score of ≤ 2 on modified Bromage scale in the deltoid and bíceps; absent sensation to cold and pinprick sensation in C5 and C6 dermatomes within 30 minutes of injection. To evaluate phrenic nerve, diaphragmatic excursion will be assessed by ultrasonography of ipsilateral hemidiaphragm and with impedance tomography. Moreover, 6 mL of methylene blue will be injected into cadavers to evaluate if dispersion was restricted to fibers of the superior trunk and don't reach phrenic nerve. |
| Masking: | None (Open Label) |
| Primary Purpose: | Basic Science |
| Official Title: | Clinical And Anatomic Study Of An Ultrasound-Guided Selective Block Of The Superior Trunk Of The Brachial Plexus. Description Of A New Approach |
| Actual Study Start Date : | April 9, 2018 |
| Estimated Primary Completion Date : | September 1, 2018 |
| Estimated Study Completion Date : | October 1, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Bupivacaine - Superior Trunk Block
Patients scheduled for rotator cuff surgery received 6 mL of 0,5% bupivacaine in the superior Trunk. 6 mL of methylene blue will be injected into cadavers with the same technique. |
Procedure: Bupivacaine - Superior Trunk Block
It will be performed the superior trunk approach with local anesthestic in patients and methylene blue in cadavers. |
- Superior Trunk Successful Block [ Time Frame: within 30 minutes of injection ]Evaluate the efficacy of the block: Successful block was defined as motor score of ≤ 2 on modified Bromage scale in the deltoid and bíceps; absent sensation to cold and pinprick sensation in C5 and C6 dermatomes
- Phrenic nerve Block [ Time Frame: at 30 minutes ]Evaluate the phrenic function after the block: To evaluate phrenic nerve, diaphragmatic excursion was assessed by ultrasonography of ipsilateral hemidiaphragm
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- ASA I or II
- BMI < 35 kg/m²
- Patients scheduled for rotator cuff surgery
Exclusion Criteria:
- cognitive impairment or active psychiatric condition
- infection at the puncture site of the blockade
- coagulopathy
- history of allergy to bupivacaine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03512990
| Contact: Leonardo HC Ferraro, PhD | +5511999516103 | leohcferraro@yahoo.com.br |
| Brazil | |
| Federal University of Sao Paulo | Recruiting |
| Sao Paulo, Brazil, 04024002 | |
| Contact: Leonardo HC Ferraro, PhD +5511999516103 leohcferraro@yahoo.com.br | |
| Responsible Party: | Leonardo Henrique Cunha Ferraro, Professor, Federal University of São Paulo |
| ClinicalTrials.gov Identifier: | NCT03512990 |
| Other Study ID Numbers: |
Superior Trunk |
| First Posted: | May 1, 2018 Key Record Dates |
| Last Update Posted: | May 1, 2018 |
| Last Verified: | April 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Brachial Plexus Block Superior Trunk Phrenic Nerve |
|
Bupivacaine Anesthetics, Local Anesthetics Central Nervous System Depressants |
Physiological Effects of Drugs Sensory System Agents Peripheral Nervous System Agents |

